This will be the first Russian developed pharmaceutical registered in Russia for 20 years, and this is a world class pharamceutical. The media coverage on this in Russia should be massive!
Image what would happen if every Russian wanted to buy just one share in the company (150m) or if 1% of the population bought just 100 shares (again 150m). What about the institutions. The mind boggles.
von.